Viability and Longevity of Human Miniaturized Living Myocardial Slices

Journal Article (2025)
Author(s)

Ziyu Zhou (Erasmus MC)

Yvar P. van Steenis (Erasmus MC)

Surya Henry (Erasmus MC)

Elisa C.H. van Doorn (Erasmus MC)

Jorik H. Amesz (Erasmus MC)

Pieter C. van de Woestijne (Erasmus MC)

Natasja M.S. de Groot (TU Delft - Electrical Engineering, Mathematics and Computer Science, Erasmus MC)

Olivier C. Manintveld (Erasmus MC)

Beatrijs Bartelds (Erasmus MC)

Yannick J.H.J. Taverne (Erasmus MC)

Research Group
Signal Processing Systems
DOI related publication
https://doi.org/10.3390/jcdd12070269 Final published version
More Info
expand_more
Publication Year
2025
Language
English
Research Group
Signal Processing Systems
Journal title
Journal of Cardiovascular Development and Disease
Issue number
7
Volume number
12
Article number
269
Downloads counter
152
Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Abstract

Living myocardial slices (LMSs) have shown great promise in cardiac research, allowing multicellular and complex interplay analyses with disease and patient specificity, yet their wider clinical use is limited by the large tissue sizes usually required. We therefore produced mini-LMSs (<10 mm2) from routine human cardiac surgery specimens and compared them with medium (10–30 mm2) and large (>30 mm2) slices. Size effects on biomechanical properties were examined with mathematical modeling, and viability, contraction profiles, and histological integrity were followed for 14 days. In total, 34 mini-, 25 medium, and 30 large LMS were maintained viable, the smallest measuring only 2 mm2. Peak twitch force proved to be size-independent, whereas time-to-peak shortened as slice area decreased. Downsized LMSs displayed excellent contractile behavior for five to six days, after which a gradual functional decline and micro-architectural changes emerged. These findings confirm, for the first time, that mini-LMSs are feasible and viable, enabling short-term, patient-specific functional studies and pharmacological testing when tissue is scarce.